Say Hello to BrainGuide

Our new platform BrainGuide™ was featured on Good Morning America. It empowers people of all ages and communities to understand and take action on brain health and Alzheimer's disease.

Aducanumab and UsAgainstAlzheimer's

Aducanumab is a proposed treatment for early Alzheimer’s disease that is intended to slow the progression of the disease. UsAgainstAlzheimer’s (UsA2) has urged the U.S. Food and Drug Administration to approve aducanumab.

UsAgainstAlzheimer’s Survey Shows Alzheimer’s Patients Value a New Therapy that Slows Progression of Symptoms

New survey results from UsAgainstAlzheimer’s A-LIST shows that patients want FDA to weigh willingness of people with MCI/mild Alzheimer’s to take a disease-modifying therapy.

Paid Leave Alliance for Dementia Caregivers Applauds American Rescue Plan but Urges Action on Paid Leave Support for Caregivers

The Paid Leave Alliance for Dementia Caregivers commends the Biden-Harris for making support for working families a top priority in its $1.9 trillion COVID-19 economic relief proposal but urges the administration to clarify how the proposal's paid leave expansions will cover Americans who care for older adults.

UsAgainstAlzheimer’s Commends Apple and Biogen for New Research on Monitoring Brain Health

UsAgainstAlzheimer’s commends Apple and Biogen for their investment in brain health research and working towards creating innovative technologies that would allow consumers to be more aware and in control of their brain health.

Say Hello to BrainGuide

Aducanumab and UsAgainstAlzheimer's

UsAgainstAlzheimer’s Survey Shows Alzheimer’s Patients Value a New Therapy that Slows Progression of Symptoms

Paid Leave Alliance for Dementia Caregivers Applauds American Rescue Plan but Urges Action on Paid Leave Support for Caregivers

UsAgainstAlzheimer’s Commends Apple and Biogen for New Research on Monitoring Brain Health

UsAgainstAlzheimer's: Working to End Alzheimer's Disease  

The Alzheimer’s pandemic is the health and social economic crisis of this generation. It is a national and global emergency that has a devastating health, social and economic toll on millions of people living with this disease, their families and caregivers.

UsAgainstAlzheimer’s exists to conquer Alzheimer’s disease. Since our founding in 2010, we have taken on the toughest problems in the fight to end Alzheimer’s. Our work is driven by the urgency to find effective treatments and the prevention steps needed to reach the time where no one is lost to Alzheimer’s.

We bring all of “Us” together to:

In the past decade, progress has been made, with more hope on the horizon now than ever before.

But every day of delay is another day lost to the millions of people affected by this devastating disease. If nothing changes, by 2050, 14 million Americans will be living with Alzheimer’s at an annual cost of more than $1 trillion. The time to act is now.

Recent News and Blog Posts

  • August 05, 2020

    New Study Finds Alzheimer’s Outranks Cancer, Infectious Diseases such as COVID-19, Stroke and Heart Attack as Most-Feared Chronic Disease by Retirees

    UsAgainstAlzheimer’s issued the following statement on the latest findings in the 2020...

    Read more
  • August 3, 2020

    August 3, 2020

    Read more
  • July 31, 2020

    COVID-19 Pandemic Closings and Isolation Could be Leading to Declines for People Living with Alzheimer’s

    The ongoing COVID-19 closures and restrictions, which have stretched nearly five months...

    Read more
  • July 30, 2020

    UsAgainstAlzheimer’s Hails New Lancet Commission Findings that Up to 40 Percent of Dementia Cases Could be Prevented or Delayed

    UsAgainstAlzheimer’s (UsA2) today applauded The Lancet Commission’s release of new research showing...

    Read more
  • July 30, 2020

    July 30, 2020

    A July 28, 2020 UsAgainstAlzheimer’s press statement quoted Co-Founder and Chairman George Vradenburg...

    Read more
  • July 29, 2020

    New UsAgainstAlzheimer’s Research Shows What Matters Most to Patients and Caregivers in Drug Treatments

    UsAgainstAlzheimer’s (UsA2) today released five publications delivering first-of-their kind findings on outcomes...

    Read more

Reports

  • Resources
    Thumbnail

    A-LIST Pulse of the Community: Volume 7, December 2020

    The UsAgainstAlzheimer’s A-LIST® is an online community of more than 8,000 people living with Alzheimer’s and other dementias, current and former caregivers, and those concerned about brain health, who have...

  • Resources
    Thumbnail

    Place & Brain Health Equity: Understanding the County-Level Impacts of Alzheimer’s

    The effects of where people live, and the social determinants of health are under-recognized and under-appreciated in our national response to effectively treat and prevent Alzheimer’s. This report found that...

  • Resources
    Thumbnail

    2019 Annual Report

    In these pages, you will find highlights of the game-changing accomplishments and tremendous progress of UsAgainstAlzheimer's and our partners in the year of 2019.